Abstract
In 2008, Guinea-Bissau introduced artemether-lumefantrine for treatment of uncomplicated malaria. Previously, 3 times the standard dose of chloroquine, that was probably efficacious against Plasmodium falciparum with the resistance-associated chloroquine-resistance transporter (pfcrt) 76T allele, was routinely used. The present study compared the efficacy and tolerability of a double standard dose of chloroquine with the efficacy and tolerability of artemether-lumefantrine.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | The Journal of Infectious Diseases |
| Vol/bind | 203 |
| Udgave nummer | 1 |
| Sider (fra-til) | 109-16 |
| Antal sider | 8 |
| ISSN | 0022-1899 |
| DOI | |
| Status | Udgivet - 1. jan. 2011 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver